A new assay based on fluorescence resonance energy transfer to determine the binding affinity of Bcl-xL inhibitors

We developed a new assay of Bcl-xsub(L) inhibitors based on fluorescence resonance energy transfer that occurs between an AEDANS-labeled Bak-BH3 peptide and three tryptophans in the BH1 and BH2 domains of Bcl-xsub(L). The method can tolerate up to 5% DMSO, and it was validated with several Bcl-xsub(...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioscience, biotechnology, and biochemistry biotechnology, and biochemistry, 2008-07, Vol.72 (7), p.1936-1939
Hauptverfasser: Feng, Y.(Chinese Academy of Sciences, Shanghai (China). Shanghai Inst. of Materia Medica), Shen, X, Chen, K, Jiang, H, Liu, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We developed a new assay of Bcl-xsub(L) inhibitors based on fluorescence resonance energy transfer that occurs between an AEDANS-labeled Bak-BH3 peptide and three tryptophans in the BH1 and BH2 domains of Bcl-xsub(L). The method can tolerate up to 5% DMSO, and it was validated with several Bcl-xsub(L) inhibitors. It can be adapted to screen for compounds targeting other Bcl-2 family proteins.
ISSN:0916-8451
1347-6947
DOI:10.1271/bbb.70735